Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy
Authors:
- 21 November 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 30 (3) , 1-8
Abstract
SUMMARY. Transoral incisionless fundoplication (TIF) using the EsophyX device has been shown to be effective and safe in patients with Gastroesophageal refluxKeywords
This publication has 32 references indexed in Scilit:
- Reported Side Effects and Complications of Long-term Proton Pump Inhibitor Use: Dissecting the EvidenceClinical Gastroenterology and Hepatology, 2013
- Guidelines for the Diagnosis and Management of Gastroesophageal Reflux DiseaseAmerican Journal of Gastroenterology, 2013
- Laparoscopic Antireflux Surgery vs Esomeprazole Treatment for Chronic GERDJAMA, 2011
- Comparison of Outcomes Twelve Years After Antireflux Surgery or Omeprazole Maintenance Therapy for Reflux EsophagitisClinical Gastroenterology and Hepatology, 2009
- Systematic review: frequency and reasons for consultation for gastro‐oesophageal reflux disease and dyspepsiaAlimentary Pharmacology & Therapeutics, 2009
- American Gastroenterological Association Medical Position Statement on the Management of Gastroesophageal Reflux DiseaseGastroenterology, 2008
- Complications and frequency of redo antireflux surgery in Denmark: a nationwide study, 1997–2005Surgical Endoscopy, 2007
- New algorithm for the treatment of gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 2007
- Persistence and adherence to proton pump inhibitors in daily clinical practiceAlimentary Pharmacology & Therapeutics, 2006
- Review article: From gastrin to gastro‐oesophageal reflux disease – a century of acid suppressionAlimentary Pharmacology & Therapeutics, 2006